How (molecular) pathologists can profile patients

S. Stephan-Falkenau (Berlin, Germany)

Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Session: PG1 Lung cancer: the key multidisciplinary approach
Session type: Postgraduate Course
Number: 83
Disease area: -

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Stephan-Falkenau (Berlin, Germany). How (molecular) pathologists can profile patients. International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017



Clinical, histological and molecular characteristics of lung cancer in patients under 30 years-old.
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018



Rescue2-Monitor (R2M) study: an overview of screened patients.
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


A network analysis of clinical characteristics of patients with COPD: partial results.
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018

Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine
Source: Eur Respir J 2005; 26: Suppl. 49, 537s
Year: 2005

Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010


Time to diagnostic procedures and treatment in outpatients diagnosed of lung cancer (LC) included in our rapid diagnose protocol (RPD)
Source: Annual Congress 2011 - How to improve lung cancer care
Year: 2011



Kaposi‘s sarcoma (particular features of clinic, diagnosis and results of treatment)
Source: Eur Respir J 2005; 26: Suppl. 49, 539s
Year: 2005

Clinical implications of diagnosing underlying chronic bronchitis (CB) in at-risk patients (pts) with acute bronchitis (AB) visiting general practitioners (GPs)
Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Year: 2008


More than 50% of patients visit a general practitioner (GP), general physician (Gen P) or a pediatrician (P) in India for respiratory symptoms: Results of a one-day point-prevalence study in 2,04,912 patients across 22 states and 5 union territories in India
Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care
Year: 2012

An influence of informational and educational prevention arrangements (IEA) of nosocomial pneumonia (NP) carried out among the surgeons on the NP level in general surgical departments (GSD)
Source: Eur Respir J 2005; 26: Suppl. 49, 188s
Year: 2005

A usefulness of 25G core needles for immunohistochemistry and molecular testing in lung cancer patients – a feasibility study
Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration
Year: 2019


MCS (multiple chemical sensitivity) patients‘ stress during clinical examinations
Source: Annual Congress 2008 - The air we breathe indoors and outdoors
Year: 2008


The sarcoidosis-tuberculosis (TB) link: molecular evidence from a high (TB) prevalence country
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009


Hypoplasia of lung (frequency, particular features of course, clinic, diagnosis, results of treatment)
Source: Eur Respir J 2007; 30: Suppl. 51, 650s
Year: 2007

The clinical current of tuberculosis in patients with different genetic markers
Source: Eur Respir J 2006; 28: Suppl. 50, 14s
Year: 2006

A statistical model to estimate lung density (LD) utilizing oscillometry (OS), biometrics (BM), patient reported outcomes (PRO) and pulmonary function tests (PFT)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Is it possible to predict response to cancer chemotherapy (CTh) in patients (pts) with non-small cell lung cancer (NSCLC) on the basis of serum CYFRA 21-1 level (sCY21)?
Source: Eur Respir J 2002; 20: Suppl. 38, 74s
Year: 2002

Clinical, radiological and bacteriological features in geriatric tuberculosis (TB) patients (pts) - initial treatment and outcome
Source: Eur Respir J 2002; 20: Suppl. 38, 363s
Year: 2002

Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007